Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Paweł K. Kunicki"'
Autor:
Paweł K. Kunicki, Aleksandra Wróbel
Publikováno v:
Molecules, Vol 26, Iss 23, p 7252 (2021)
The aim of the work was to prepare a simple but reliable HPLC-UV method for the routine monitoring of mycophenolic acid (MPA). Sample preparation was based on plasma protein precipitation with acetonitrile. The isocratic separation of MPA and interna
Externí odkaz:
https://doaj.org/article/6e7d44d13c40456e935aba2ac643c3d6
Publikováno v:
Therapeutic Drug Monitoring. 45:173-190
Publikováno v:
Journal of Chromatography B. 1104:220-227
The aim of this work was to develop and to validate LC–MS/MS method for tacrolimus (TAC) determination in whole blood samples using two different types of internal standards (IS): an isotope-labeled TAC13C,D2 and a structural analog ascomycin (ASC)
Autor:
Mercè Brunet, Eberhard Wieland, Alexander A. Vinks, Pierre Wallemacq, Nils Tore Vethe, Nicolas Picard, Dirk Jan A.R. Moes, Mariadelfina Molinaro, Paweł K. Kunicki, Klemens Budde, Satohiro Masuda, Maja Theresa Dieterlen, Tomoyuki Mizuno, Stein Bergan, Laure Elens, Anders Åsberg, Olga Millán, Florian Lemaitre, Burkhard Tönshoff, Maria Shipkova, Jesse J. Swen, Teun van Gelder, Tomasz Pawinski, Vincent Haufroid, Ofelia Noceti, Tom C. Zwart, Pierre Marquet, Smita Pattanaik, Jean-Baptiste Woillard, Loralie J. Langman, Markus J. Barten, Dennis A. Hesselink, Ron H.N. van Schaik, Michael Oellerich, Christoph Seger, Linda Salzmann, Kamisha L. Johnson-Davis, Raman Venkataramanan
Publikováno v:
Therapeutic Drug Monitoring, Vol. 43, no.2, p. 150-200 (2021)
Therapeutic Drug Monitoring
Therapeutic Drug Monitoring, Lippincott, Williams & Wilkins, 2021, 43 (2), pp.150-200. ⟨10.1097/FTD.0000000000000871⟩
Therapeutic Drug Monitoring, 2021, 43 (2), pp.150-200. ⟨10.1097/FTD.0000000000000871⟩
Therapeutic Drug Monitoring, 43(2), 150-200. LIPPINCOTT WILLIAMS & WILKINS
Therapeutic Drug Monitoring
Therapeutic Drug Monitoring, Lippincott, Williams & Wilkins, 2021, 43 (2), pp.150-200. ⟨10.1097/FTD.0000000000000871⟩
Therapeutic Drug Monitoring, 2021, 43 (2), pp.150-200. ⟨10.1097/FTD.0000000000000871⟩
Therapeutic Drug Monitoring, 43(2), 150-200. LIPPINCOTT WILLIAMS & WILKINS
When mycophenolic acid (MPA) was originally marketed for immunosuppressive therapy, fixed doses were recommended by the manufacturer. Awareness of the potential for a more personalized dosing has led to development of methods to estimate MPA area und
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50b1cf2bb23290633f56b83d70251d51
https://hdl.handle.net/2078.1/249100
https://hdl.handle.net/2078.1/249100
Publikováno v:
Therapeutic Drug Monitoring. 41:406-408
Autor:
Paweł K. Kunicki, Jacek Jamiołkowski, Paweł Bekta, Adam Witkowski, Krzysztof Kukuła, Mariusz Kłopotowski, Artur Debski, Zbigniew Chmielak
Publikováno v:
Blood Coagulation & Fibrinolysis. 28:383-388
Platelet aggregation monitoring in patients after stent implantation is a promising way of preventing stent thrombosis and bleeding. The aim of the study was to verify whether clopidogrel (ADPtest) and aspirin (ASPItest) response measured by Multipla
Autor:
Jean-Baptiste Woillard, Uwe Christians, Dirk Jan A.R. Moes, Claudia Sommerer, Nicolas Picard, Tomasz Pawinski, Brenda C. M. de Winter, Markus J. Barten, Tomoyuki Mizuno, Pierre Wallemacq, Florian Lemaitre, Kamisha L. Johnson-Davis, Nils Tore Vethe, Pierre Marquet, Binu S. Mathew, Ron H.N. van Schaik, Iain MacPhee, Loralie J. Langman, Dennis A. Hesselink, Christoph Seger, Teun van Gelder, Alexander A. Vinks, Paweł K. Kunicki, Vincent Haufroid, Stein Bergan, Klemens Budde, Satohiro Masuda, Mercè Brunet, Eberhard Wieland, Caroline Monchaud, Helena Colom, Maria Shipkova, Ofelia Noceti, Laure Elens, Olga Millán, Maja Theresa Dieterlen, Anders Åsberg
Publikováno v:
Therapeutic Drug Monitoring, 41(3), 261-307. Lippincott Williams & Wilkins
Therapeutic Drug Monitoring
Therapeutic Drug Monitoring, Lippincott, Williams & Wilkins, 2019, 41 (3), pp.261-307. ⟨10.1097/FTD.0000000000000640⟩
Therapeutic Drug Monitoring, 41(3), 261-307
Therapeutic Drug Monitoring, 2019, 41 (3), pp.261-307. ⟨10.1097/FTD.0000000000000640⟩
Therapeutic drug monitoring, Vol. 41, no.3, p. 261-307 (2019)
Therapeutic Drug Monitoring
Therapeutic Drug Monitoring, Lippincott, Williams & Wilkins, 2019, 41 (3), pp.261-307. ⟨10.1097/FTD.0000000000000640⟩
Therapeutic Drug Monitoring, 41(3), 261-307
Therapeutic Drug Monitoring, 2019, 41 (3), pp.261-307. ⟨10.1097/FTD.0000000000000640⟩
Therapeutic drug monitoring, Vol. 41, no.3, p. 261-307 (2019)
International audience; Ten years ago, a consensus report on the optimization of tacrolimus was published in this journal. In 2017, the Immunosuppressive Drugs Scientific Committee of the International Association of Therapeutic Drug Monitoring and C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e9f00168e1d0fa4d232dd8058bcdc16
https://pure.eur.nl/en/publications/111d5c63-b5aa-483e-a2b6-ea778ee98946
https://pure.eur.nl/en/publications/111d5c63-b5aa-483e-a2b6-ea778ee98946
Autor:
Paulina Łuszczyńska, Hanna Augustyniak-Bartosik, Magdalena Hurkacz, Magdalena Durlik, Tomasz Pawinski, Paweł K. Kunicki
Publikováno v:
European journal of clinical pharmacology. 75(3)
To evaluate the relationship between total and free MPA pharmacokinetic (PK) parameters and renal outcome markers, and to verify whether conducting therapeutic drug monitoring (TDM) in lupus nephritis (LN) patients would be of value in routine clinic
Autor:
Mariusz Kłopotowski, Mateusz Śpiewak, Witold Rużyłło, Adam Witkowski, Paweł K. Kunicki, Łukasz A. Małek, Joanna Waś
Publikováno v:
Cor et Vasa. 55:e126-e130
BackgroundOutcome in ST-segment elevation myocardial infarction (STEMI) is affected by patency of the infarct-related artery (IRA) on the initial angiogram. There is a controversy if preloading with antiplatelet drugs affects initial IRA patency in c
Autor:
Joanna Waś, Paweł K. Kunicki
Publikováno v:
Journal of Chromatography B. 911:133-139
The paper presents an HPLC method for cefazolin determination in human serum. The preparation step was based on serum protein precipitation with acetonitrile followed by supernatant evaporation and sample reconstitution in water before injection. The